Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

Tue, 15th Dec 2015 09:46

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning and Monday:
----------
FTSE 100
----------
BERENBERG RAISES MEGGITT TO 'BUY' ('HOLD') - TARGET 445 (536) PENCE
----------
LIBERUM CUTS SPORTS DIRECT PRICE TARGET TO 810 (950) PENCE - 'BUY'
----------
BARCLAYS CUTS MARKS & SPENCER PRICE TARGET TO 500 (550) PENCE - 'EQUAL WEIGHT'
----------
UBS CUTS MARKS & SPENCER PRICE TARGET TO 630 (640) PENCE - 'BUY'
----------
DAVY CUTS WOLSELEY TO 'NEUTRAL' ('OUTPERFORM')
----------
GOLDMAN CUTS WOLSELEY TO 'NEUTRAL' ('BUY') - TARGET 4459 (4860) PENCE
----------
CREDIT SUISSE CUTS RANDGOLD RESOURCES PRICE TARGET TO 3900 (4040) P - 'NEUTRAL'
----------
CREDIT SUISSE CUTS ANTOFAGASTA PRICE TARGET TO 400 (500) PENCE - 'UNDERPERFORM'
----------
CREDIT SUISSE CUTS RIO TINTO PRICE TARGET TO 2100 (2400) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES BHP BILLITON TO OUTPERFORM (NEUTRAL) - PRICE TARGET 900 (1100) PENCE
----------
CREDIT SUISSE CUTS ANGLO AMERICAN PRICE TARGET TO 320 (750) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 265 (450) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS NEXT PRICE TARGET TO 7750 (7800) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS PERSIMMON PRICE TARGET TO 2200 (2205) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BERKELEY GROUP PRICE TARGET TO 4100 (4075) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 690 (685) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TRAVIS PERKINS TO 'NEUTRAL' ('BUY') - TARGET 2307 (2650) PENCE
----------
GOLDMAN CUTS UNILEVER PLC PRICE TARGET TO 2600 (2760) PENCE - 'SELL'
----------
FTSE 250
----------
JEFFERIES CUTS IMI PRICE TARGET TO 870 (1150) PENCE - 'HOLD'
----------
NOMURA RAISES IMI PRICE TARGET TO 972 (955) PENCE - 'BUY'
----------
JEFFERIES CUTS ESSENTRA PRICE TARGET TO 1000 (1025) PENCE - 'BUY'
----------
PANMURE RAISES AVEVA GROUP PRICE TARGET TO 1910 (1857) PENCE - 'HOLD'
----------
BARCLAYS CUTS SHAWBROOK PRICE TARGET TO 375 (410) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS ALDERMORE PRICE TARGET TO 225 (310) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS PARAGON GROUP TO 'EQUAL WEIGHT' (OVERWEIGHT) - TARGET 375 (475) PENCE
----------
BARCLAYS CUTS ONESAVINGS BANK TO EQUAL WEIGHT (OVERWEIGHT) - TARGET 340 (375) PENCE
----------
RBC CAPITAL INITIATES CIRCASSIA PHARMACEUTICALS WITH 'TOP PICK' - TARGET 430 P
----------
DAVY RAISES SIG TO 'OUTPERFORM' ('NEUTRAL')
----------
DAVY RAISES GRAFTON GROUP TO 'OUTPERFORM' ('NEUTRAL')
----------
RBC CAPITAL INITATES VECTURA AT 'OUTPERFORM' - TARGET 210 PENCE
----------
RBC CAPITAL INITIATES INDIVIOR WITH 'UNDERPERFORM' - TARGET 140 PENCE
----------
RBC CAPITAL INITIATES DECHRA PHARMA WITH 'SECTOR PERFORM' - TARGET 1080 PENCE
----------
RBC CAPITAL INITIATES BTG WITH 'OUTPERFORM' - TARGET 820 PENCE
----------
CREDIT SUISSE CUTS VEDANTA PRICE TARGET TO 230 (430) PENCE - 'UNDERPERFORM'
----------
JPMORGAN RAISES RPC GROUP PRICE TARGET TO 415 (360) PENCE - 'OVERWEIGHT'
----------
JPMORGAN INITIATES TELECOM PLUS WITH 'OVERWEIGHT' - TARGET 1290 PENCE
----------
UBS CUTS N BROWN PRICE TARGET TO 380 (395) PENCE - 'BUY'
----------
UBS CUTS HALFORDS GROUP PRICE TARGET TO 365 (380) PENCE - 'NEUTRAL'
----------
UBS CUTS DEBENHAMS PRICE TARGET TO 70 (72) PENCE - 'SELL'
----------
UBS CUTS B&M EUROPEAN VALUE RETAIL PRICE TARGET TO 390 (400) PENCE - 'BUY'
----------
GOLDMAN CUTS FOXTONS PRICE TARGET TO 227 (254) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS CREST NICHOLSON PRICE TARGET TO 750 (760) PENCE - 'CONVICTION BUY'
----------
HSBC CUTS JIMMY CHOO PRICE TARGET TO 160 (185) PENCE - 'BUY'
----------
GOLDMAN CUTS COUNTRYWIDE PRICE TARGET TO 498 (506) PENCE - 'NEUTRAL'
----------
HSBC RAISES GREENE KING TO 'HOLD' ('REDUCE') - TARGET 870 (780) PENCE
----------
GOLDMAN CUTS BOVIS HOMES PRICE TARGET TO 1295 (1440) PENCE - 'BUY'
----------
GOLDMAN RAISES BELLWAY PRICE TARGET TO 3390 (3200) PENCE - 'BUY'
----------
GOLDMAN RAISES BALFOUR BEATTY PRICE TARGET TO 296 (276) PENCE - 'NEUTRAL'
----------
NOMURA RAISES WEIR GROUP PRICE TARGET TO 1129 (1110) PENCE - 'NEUTRAL'
----------
NOMURA RAISES ROTORK PRICE TARGET TO 158 (155) PENCE - 'REDUCE'
----------
GOLDMAN RAISES REDROW TO 'BUY' ('NEUTRAL')
----------
GOLDMAN CUTS HOWDEN JOINERY TO 'SELL' ('NEUTRAL') - TARGET 565 (568) PENCE
----------
Liberum Cuts SuperGroup To Hold From Buy, Price Target 1,500p
----------
Numis Cuts Investec Price Target To 496p From 609p, Maintains Add
----------
MAIN MARKET AND AIM
----------
PEEL HUNT RAISES CARPETRIGHT PRICE TARGET TO 575 PENCE - 'BUY'
----------
JEFFERIES CUTS HARGREAVES SERVICES PRICE TARGET TO 270 (325) PENCE - 'HOLD'
----------
RBC CAPITAL INITIATES CLINIGEN WITH 'OUTPERFORM' - TARGET 770 PENCE
----------
CREDIT SUISSE CUTS FERREXPO PRICE TARGET TO 15 (30) PENCE - 'UNDERPERFORM'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

Read more
13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

Read more
13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

Read more
13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Read more
14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

Read more
28 May 2020 13:34

Thursday broker round-up

(Sharecast News) - Provident Financial: RBC Capital Markets reiterates sector performer with a target price of 195p.

Read more
28 May 2020 09:37

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more
12 May 2020 10:37

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

Read more
16 Apr 2020 12:00

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Read more
24 Mar 2020 16:00

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
18 Mar 2020 13:42

Wednesday broker round-up

(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
11 Mar 2020 13:37

Wednesday broker round-up

(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.